Abstract

The title compound, [RuCl2(C10H14)(C26H35O2P)] (I), crystallizes in the monoclinic space group P21/c with two crystallographically independent mol-ecules (A and B) in the asymmetric unit. The geometries of both mol-ecules are very similar and distinguished only by the twist angles of the two benzene rings in the phosphine substituents [89.54 (14) and 78.36 (14)° for mol-ecules A and B, respectively]. The Ru atoms have classical pseudo-tetra-hedral piano-stool coordination environments. The conformation of each mol-ecule is stabilized by intra-molecular C-H⋯O and C-H⋯Cl hydrogen bonds and C-H⋯π inter-actions. The two mol-ecules are linked by a C-H⋯Cl hydrogen bond. In the crystal, the mol-ecules are further linked by C-H⋯ π inter-actions, forming -A-B-A-B- chains propagating along the a-axis direction. Complex I is an active catalyst for reductive amination reaction. The catalytic activity of this complex can be explained by the lability of the p-cymene ligand, which can be replaced by two-electron ligands such as CO or amine.

Highlights

  • The conformation of each molecule is stabilized by intramolecular C—HÁ Á ÁO and C—HÁ Á ÁCl hydrogen bonds and C—HÁ Á Á interactions

  • The two molecules are linked by a C—HÁ Á ÁCl hydrogen bond

  • The molecules are further linked by C—HÁ Á Á interactions, forming –A–B–A–B– chains propagating along the a-axis direction

Read more

Summary

Chemical context

The design of new organometallic complexes is important for the development of new catalytic processes as well as for understanding those already known. Symmetry codes: (i) x À 1; y; z; (ii) x þ 1; y; z Such 6-arene RuII complexes with piano-stool coordination are known to be active catalysts in different processes (Therrien, 2009), including hydrogenation (Moldes et al, 1998), hydroboration (Kaithal et al, 2016), transfer hydrogenation (Aznar et al, 2013; Ceron-Camacho et al, 2006; Clavero et al, 2016) and isomerization of allylic alcohols (Dıaz-Alvarez et al, 2006; Baraut et al, 2015). Such complexes have shown promising medicinal properties (Nazarov et al, 2014), including anticancer activity (Chuklin et al, 2017)

Structural commentary
Catalytic activity
Procedure for reductive amination
Synthesis and crystallization
Refinement

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.